Members will now have direct access to Aerogen’s award-winning aerosol drug delivery technology
Aerogen
Who we are
Aerogen® is the world leader in acute care aerosol drug delivery. The Aerogen Solo is a closed-circuit system. This single-patient-use aerosol drug delivery technology mitigates the transmission of patient-generated infectious aerosol during ventilation. Aerogen has been used to treat over 30 million patients1 in 80 countries1.
Aerogen
News
We are delighted to introduce the world’s first self-delivering medical device.
Druid has announced an exciting new Community and Education programme aimed at deepening engagement with professional theatre within education and local community settings.
Following months of collaborative development work, Aerogen® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial supply partnership ...
Today is World Prematurity Day , a day to raise awareness of preterm birth.
The Galway Chamber is an organisation operating under the stewardship of a voluntary Council of 25 members, supported by six committees...
Aerogen has been at the forefront of medical response to the pandemic with our products being used with over 3 million hospitalized and critically ill patients since March 2020.
Galway Women’s FC is delighted to announce a new educational partnership with Galway based med-tech company Aerogen.
Company’s aerosol drug delivery technology used in Phase 1 clinical trial to deliver inhaled type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults without COVID-19 from China.
The National Patient Safety Agency recently issued an alert (NatPSA/2021/003/NHSPS) necessitating organisations to "purchase sufficient powered nebuliser devices for use across the organisation...
UNICEF and Aerogen have announced a two-year partnership in support of UNICEF’s work in the areas of global vaccine equity and the health of newborns.
Aerogen have been shortlisted for two awards in the 46th Business & Finance Awards, in association with KPMG Ireland.
Aerogen, Ireland’s largest indigenous medtech company, has announced the establishment of a new manufacturing operation in Shannon ...
The Irish Medtech Association, the Ibec group that represents the medtech sector, Enterprise Ireland and IDA Ireland have announced that...
A new collaboration between researchers at CÚRAM, the SFI Research Centre based at NUI Galway and Industry partner Aerogen, a world leader ...
EI funded project aims to improve the efficacy of pulmonary drug delivery systems in ICUs
Aerogen has signed an agreement with Synairgen plc, a Southampton, UK-based biotechnology company, to provide the market-leading Aerogen® Solo/Ultra...
NUI Galway, OmniSpirant Limited and Aerogen Limited have been awarded major funding to develop a new aerosol treatment that will transform respiratory medicine...
In a year which will be heralded as one of the toughest that healthcare has had to endure...
Aerogen sponsors Galway International Arts Festival’s Galway 2020 project.
Aerogen
Media Contacts
Media Contacts
Before publishing any piece on Aerogen we invite you to reach out to our communications team who can provide further clarity where required. The mailbox media@aerogen.com is monitored consistently and is the most efficient way to reach the communications team. Please note, only media enquiries will be responded to. If you have other needs and are looking to contact another group at Aerogen, please visit the contact page
Aerogen
Follow Aerogen
- Aerogen Data on File.
